The Clinical and Economic Impacts of e-Heath on Diabetes
NCT ID: NCT01595269
Last Updated: 2012-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
79 participants
INTERVENTIONAL
2007-04-30
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. There will be no difference will be found in the use of the search engine and the information accessed among the three education modes.
2. There will be no difference in education mode's effect on metabolic control, self-care management practices, and medical resource utilization.
3. There will be no difference in the economic impact on the health care system based on differing education modes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ehealth: Second Life Impacts Diabetes Education & Self-Management
NCT01186965
Online Support for Diabetes Self-Management
NCT02504086
The Effectiveness of Diabetes Patient Education and Self-Management Education in Persons With Type 2 Diabetes
NCT00906919
Internet-based Diabetes Education and Case Management
NCT00105898
Web-based Dietary Intervention for Diabetic Patients
NCT01246687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Education mode 1 (control)
Education mode 1 (control) is comprised of participants educated using CHR's current traditional face-to-face delivery method, with printed materials and written log journals. These participants will be trained to use the University's web portal if they elect to access internet-based diabetes information. This allows for the tracking of the type and amounts of diabetes information accessed by participants.
eHealth education
In addition to the face-to-face education process currently used at the CHR, Education mode 1 (control), Education mode 2 (static interface) and Education mode 3 (dynamic interface) will be used.
Education mode 2 (static interface)
Education mode 2 (static interface) participants will be educated using digitized forms of the traditional materials provided by CHR as well as an electronic log journal (e-journal) where participants will record their diabetes-related outcomes and behavioural information. Education mode 2 will be assessed and approved by CHR.
eHealth education
In addition to the face-to-face education process currently used at the CHR, Education mode 1 (control), Education mode 2 (static interface) and Education mode 3 (dynamic interface) will be used.
Education mode 3 (dynamic interface)
Education mode 3 (dynamic interface) participants will be educated using the digitized traditional materials from education mode 2 as well as an enhanced dynamic e-journal (visualization of blood glucose and alerts). In addition, this mode will provide informative disease-related internet sites and diabetes news and articles vetted by the medical team. Participants and health professionals will then be able to electronically discuss the content and quality of this information (discussion board). New sites and articles will be added on an ongoing basis. Participants will also have access to a chat room that will encourage information sharing with other education mode 3 participants and health professionals at CHR. Education mode 3 will be assessed and approved by CHR.
eHealth education
In addition to the face-to-face education process currently used at the CHR, Education mode 1 (control), Education mode 2 (static interface) and Education mode 3 (dynamic interface) will be used.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
eHealth education
In addition to the face-to-face education process currently used at the CHR, Education mode 1 (control), Education mode 2 (static interface) and Education mode 3 (dynamic interface) will be used.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Literate
* Not participating in other clinical trials
* Diabetes diagnosed within the last three months
* Type 2 diabetes
* No medical conditions that could compromise metabolic control
* No linguistic, cognitive or psychosocial barriers that would hinder study completion
* Computer and internet literate
* Access to high-speed internet
Exclusion Criteria
* Not literate
* Participating in other clinical trials
* Diabetes diagnosed greater than three months ago
* Type 1 diabetes
* Gestational diabetes
* Additional medical conditions that could compromise metabolic control
* Linguistic, cognitive or psychosocial barriers that would hinder study completion
* Not computer and internet literate
* No access to high-speed internet
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Lawson Foundation
OTHER
Dr. Danièle Pacaud
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Danièle Pacaud
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angela M Downey, PhD, CMA, FCMA
Role: PRINCIPAL_INVESTIGATOR
University of Lethbridge
Helen Kelley, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Lethbridge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Calgary Health Region's offices across southwestern Alberta
Lethbridge, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LAWSON-686
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.